Pub Date : 2025-03-06eCollection Date: 2025-01-01DOI: 10.3205/dgkh000538
Isah Musa Maishanu, Adeshina O Gbonjubola, Hussaini Mujahid, Busayo O Olayinka
Aim: This study was carried out to isolate and detect virulence genes associated with Staphylococcus (S.) aureus clinical isolates from the Federal Medical Center Birnin Kebbi, Nigeria.
Methods: To obtain S. aureus isolates, samples were taken from urine, sputum, blood and wound sources. S. aureus was phenotypically identified using Microgen staph ID system and PSM-mec and PVL genes were detected using polymerase chain reaction (PCR).
Results: A total of 48 non-duplicate S. aureus isolates were obtained (21 from wound swabs, 7 from blood, 15 from urine, and 5 from sputum). From the 14 S. aureus isolates examined by PCR, the most abundant gene was PSM-mec (42.8%), while the PVL was the least abundant with 21.4%.
Conclusion: Because it gives highly specific and accurate results, it is essential to use the PCR technique to detect S. aureus virulence determinants as well as PSM-mec and PVL as targets for antimicrobial agents.
{"title":"Molecular detection of phenol-soluble modulin-mec (PSM-mec) in Staphylococcus aureus clinical isolates from Federal Medical Center Birnin Kebbi, North-West, Nigeria.","authors":"Isah Musa Maishanu, Adeshina O Gbonjubola, Hussaini Mujahid, Busayo O Olayinka","doi":"10.3205/dgkh000538","DOIUrl":"https://doi.org/10.3205/dgkh000538","url":null,"abstract":"<p><strong>Aim: </strong>This study was carried out to isolate and detect virulence genes associated with <i>Staphylococcus (S.) aureus</i> clinical isolates from the Federal Medical Center Birnin Kebbi, Nigeria.</p><p><strong>Methods: </strong>To obtain <i>S. aureus</i> isolates, samples were taken from urine, sputum, blood and wound sources. <i>S. aureus</i> was phenotypically identified using Microgen staph ID system and PSM-mec and PVL genes were detected using polymerase chain reaction (PCR).</p><p><strong>Results: </strong>A total of 48 non-duplicate <i>S. aureus</i> isolates were obtained (21 from wound swabs, 7 from blood, 15 from urine, and 5 from sputum). From the 14 <i>S. aureus</i> isolates examined by PCR, the most abundant gene was <i>PSM-mec</i> (42.8%), while the PVL was the least abundant with 21.4%.</p><p><strong>Conclusion: </strong>Because it gives highly specific and accurate results, it is essential to use the PCR technique to detect <i>S. aureus</i> virulence determinants as well as PSM-mec and PVL as targets for antimicrobial agents.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc09"},"PeriodicalIF":1.7,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059804/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144013626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-06eCollection Date: 2025-01-01DOI: 10.3205/dgkh000537
Maren Eggers, Katrin Steinhauer, Florin H H Brill
{"title":"Letter to the editor regarding the paper \"S2k-Guideline hand antisepsis and hand hygiene\".","authors":"Maren Eggers, Katrin Steinhauer, Florin H H Brill","doi":"10.3205/dgkh000537","DOIUrl":"https://doi.org/10.3205/dgkh000537","url":null,"abstract":"","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc08"},"PeriodicalIF":1.7,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059810/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144014078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-05eCollection Date: 2025-01-01DOI: 10.3205/dgkh000534
Maren Eggers, Nils-Olaf Hübner, Ulrike Helber-Soszynski, Johannes Blümel, Martin Exner, Jürgen Gebel, Carola Ilschner, Holger F Rabenau, Ingeborg Schwebke, Martin Enders
Background: In 2024, there has been a notable surge in the incidence of infections with parvovirus B19 (B19V). This development presents significant challenges, particularly for pregnant women, daycare centers, and medical facilities with vulnerable patients.
Properties of b19v: B19V is transmitted primarily by droplet infection, directly and indirectly through contaminated surfaces. It is highly contagious and can have serious health consequences for at-risk groups, especially for pregnant women and immunocompromised individuals. There is not yet much data available on the specific tenacity/replication capacity of B19V, which is why empirical values from animal parvoviruses regarding sensitivity to disinfectants are used.
Recommendations for hygiene measures: In order to prevent the further spread of B19V, an advisory has been prepared by experts from the Association for Applied Hygiene (VAH), in collaboration with the "Virus Disinfection" commission of the German Association for the Control of Virus Diseases (DVV) and the Society for Virology (GfV). This advisory is based on a risk assessment and the specific properties of B19V, and it outlines the necessary hygiene measures, including the selection of suitable disinfectants, to be taken in various areas in order to prevent the virus from spreading further. In the domestic setting, fundamental hygiene practices include thorough handwashing, refraining from touching the eyes, mouth, and nose, the use of a medical mask in the absence of physical distancing, and the frequent ventilation of rooms. In a medical setting, for example, the disinfection of surfaces in close proximity to the patient with an active virucidal agent and the use of gloves are also recommended when dealing with infected or potentially infected individuals.
{"title":"Hygiene and disinfection measures for parvovirus B19 infections.","authors":"Maren Eggers, Nils-Olaf Hübner, Ulrike Helber-Soszynski, Johannes Blümel, Martin Exner, Jürgen Gebel, Carola Ilschner, Holger F Rabenau, Ingeborg Schwebke, Martin Enders","doi":"10.3205/dgkh000534","DOIUrl":"https://doi.org/10.3205/dgkh000534","url":null,"abstract":"<p><strong>Background: </strong>In 2024, there has been a notable surge in the incidence of infections with parvovirus B19 (B19V). This development presents significant challenges, particularly for pregnant women, daycare centers, and medical facilities with vulnerable patients.</p><p><strong>Properties of b19v: </strong>B19V is transmitted primarily by droplet infection, directly and indirectly through contaminated surfaces. It is highly contagious and can have serious health consequences for at-risk groups, especially for pregnant women and immunocompromised individuals. There is not yet much data available on the specific tenacity/replication capacity of B19V, which is why empirical values from animal parvoviruses regarding sensitivity to disinfectants are used.</p><p><strong>Recommendations for hygiene measures: </strong>In order to prevent the further spread of B19V, an advisory has been prepared by experts from the Association for Applied Hygiene (VAH), in collaboration with the \"Virus Disinfection\" commission of the German Association for the Control of Virus Diseases (DVV) and the Society for Virology (GfV). This advisory is based on a risk assessment and the specific properties of B19V, and it outlines the necessary hygiene measures, including the selection of suitable disinfectants, to be taken in various areas in order to prevent the virus from spreading further. In the domestic setting, fundamental hygiene practices include thorough handwashing, refraining from touching the eyes, mouth, and nose, the use of a medical mask in the absence of physical distancing, and the frequent ventilation of rooms. In a medical setting, for example, the disinfection of surfaces in close proximity to the patient with an active virucidal agent and the use of gloves are also recommended when dealing with infected or potentially infected individuals.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc05"},"PeriodicalIF":1.7,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059808/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144063460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-05eCollection Date: 2025-01-01DOI: 10.3205/dgkh000535
Sebastian Beltz, Stephanie Fischer, Frank Huenger, Reza Vahdad, Hermann Kalhoff, Andreas Leutner
Aim: Appendectomy is the most frequent emergency abdominal operation in children, who regularly present with complicated acute appendicitis and thus need targeted antibiotic therapy. While in other fields antibiotic stewardship (ABS) is becoming increasingly well established, these principles are not consistently followed in pediatric surgery. With this study, we aimed to analyze the effects of the implementation of an ABS-compliant SOP on the postoperative care of patients.
Material and methods: We compared the quality of antibiotic therapy before and after the implementation of standard operating procedure (SOP) for the peri-/postoperative antibiotic treatment of appendicitis in 2020. Pediatric patients who had undergone appendectomy were evaluated based on an algorithm presenting recommended antibiotic therapy of appendicitis, according to the current literature and good clinical practice. 165 patients were evaluated before and 209 patients after the implementation of SOP.
Results: The mean number of cases in which antibiotic therapy was given postoperatively was 10.5% lower (p-value 0.036) and the median quality-of-treatment score increased by 31.2% (p<0.0001) after the implementation of the SOP. The median length of antibiotic treatment in cases of advanced-stage appendicitis was 2.0 days shorter (p=0.062). The rate of oral antibiotic treatment after discharge decreased by 25.6% (p<0.0001). We observed no significant effects on the median length of hospital stay or the complication rate.
Conclusion: The implementation of SOP based on the principles of ABS positively influenced the quality of treatment after pediatric appendectomy. The algorithm developed in this study may help pediatric surgeons to improve their antimicrobial assessment.
{"title":"Better care for children with appendicitis: implementation of antibiotic stewardship optimizes postoperative therapy.","authors":"Sebastian Beltz, Stephanie Fischer, Frank Huenger, Reza Vahdad, Hermann Kalhoff, Andreas Leutner","doi":"10.3205/dgkh000535","DOIUrl":"https://doi.org/10.3205/dgkh000535","url":null,"abstract":"<p><strong>Aim: </strong>Appendectomy is the most frequent emergency abdominal operation in children, who regularly present with complicated acute appendicitis and thus need targeted antibiotic therapy. While in other fields antibiotic stewardship (ABS) is becoming increasingly well established, these principles are not consistently followed in pediatric surgery. With this study, we aimed to analyze the effects of the implementation of an ABS-compliant SOP on the postoperative care of patients.</p><p><strong>Material and methods: </strong>We compared the quality of antibiotic therapy before and after the implementation of standard operating procedure (SOP) for the peri-/postoperative antibiotic treatment of appendicitis in 2020. Pediatric patients who had undergone appendectomy were evaluated based on an algorithm presenting recommended antibiotic therapy of appendicitis, according to the current literature and good clinical practice. 165 patients were evaluated before and 209 patients after the implementation of SOP.</p><p><strong>Results: </strong>The mean number of cases in which antibiotic therapy was given postoperatively was 10.5% lower (p-value 0.036) and the median quality-of-treatment score increased by 31.2% (p<0.0001) after the implementation of the SOP. The median length of antibiotic treatment in cases of advanced-stage appendicitis was 2.0 days shorter (p=0.062). The rate of oral antibiotic treatment after discharge decreased by 25.6% (p<0.0001). We observed no significant effects on the median length of hospital stay or the complication rate.</p><p><strong>Conclusion: </strong>The implementation of SOP based on the principles of ABS positively influenced the quality of treatment after pediatric appendectomy. The algorithm developed in this study may help pediatric surgeons to improve their antimicrobial assessment.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc06"},"PeriodicalIF":1.7,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059807/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143998075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-04eCollection Date: 2025-01-01DOI: 10.3205/dgkh000533
Ursel Heudorf, Bernd Kowall
<p><strong>Introduction: </strong>Mortality during the SARS-CoV-2 pandemic was studied in many countries. The results were strongly influenced by the chosen calculation method, the adjustment to the ageing of the population and the reference periods used. Smaller-scale studies sometimes showed considerable differences within countries, but it is unclear whether the differences within a country were due to the fact that the studies were small (sampling error) or whether they were true differences. In an earlier small-scale study in Frankfurt, we examined mortality during the first two years of the pandemic. Our aim was to continue this analysis until the end of 2023, for the first time taking into account other factors influencing mortality such as influenza and heat.</p><p><strong>Method: </strong>We obtained population data for Frankfurt am Main for 2016-2023 from the Municipal Office of Statistics, City of Frankfurt/Main, mortality data from 2016 to 2023 from the Hessian State Office for Health and Care, data on SARS-CoV-2 and influenza notifications from the homepage of the Robert Koch-Institute and weather data from the homepage of the German Meteorological Office. For calculating standardized mortality ratios (SMR= observed number of deaths divided by the expected number of deaths), we multiplied the mean mortality rate for 5 age groups from 2016-2019 with the total numer of residents in those age groups in the further years or periods, and finally added the numbers of expected deaths per age group.</p><p><strong>Results: </strong>The update of the assessment of mortality adjusted for age and population trend in the years 2020-2023 in Frankfurt am Main shows an excess mortality (SMR 1.029; 95% CI 1.004-1.054, +185 excess deaths) in 2022, followed by a negative excess mortality in 2023 (SMR 0.972; 95% CI 0.948-0.996). In the years 2020 and 2021 however, no increase in excess mortality had been found (2020: SMR 0.976; 95% CI 0.951-1.001; 2021: 0.998; 95% CI 0,973-1.023). In the second wave of the SARS CoV-2 pandemic with the Wuhan type (fall 2020), a significantly increased mortality was found (SMR 1.106; 95% CI 1.066-1.147, +274 deaths), as well as during the first four waves overall (Wuhan, Alpha and Delta type) (SMR 1.023; 95 CI 1.001-1.045), whereas no increased mortality occurred during the further waves with the Omikron variant in 2022 (SMR 0.988; 95% CI 0.963-1.014). The increased mortality in 2022 was associated with an influenza wave in the last 6 weeks of the year, which had led to a strong increase in mortality (SMR 1.250; 95% CI 1.170-1.330).</p><p><strong>Discussion: </strong>During the SARS-CoV-2 pandemic, significant excess mortality occurred in Frankfurt am Main only in the second wave at the end of 2020 before vaccination was introduced; in all other waves, no significant excess mortality was recorded. Overall, there was a non-significant negative excess mortality in Frankfurt am Main in 2020 and 2021 and a significant negativ
导言:许多国家对SARS-CoV-2大流行期间的死亡率进行了研究。结果受到所选择的计算方法、对人口老龄化的调整以及所使用的参考期的强烈影响。规模较小的研究有时显示出国家内部存在相当大的差异,但尚不清楚一国内部的差异是由于研究规模小(抽样误差)还是它们确实存在差异。在法兰克福早期的一项小规模研究中,我们检查了大流行头两年的死亡率。我们的目标是将这一分析持续到2023年底,这是第一次考虑到影响死亡率的其他因素,如流感和高温。方法:我们从法兰克福/美因市市政统计局获得2016-2023年美因河畔法兰克福的人口数据,从黑森州卫生与保健办公室获得2016-2023年的死亡率数据,从罗伯特科赫研究所主页获得SARS-CoV-2和流感通报数据,从德国气象局主页获得天气数据。为了计算标准化死亡率(SMR=观察死亡人数除以预期死亡人数),我们将2016-2019年5个年龄组的平均死亡率乘以这些年龄组在后续年份或期间的居民总数,最后加上每个年龄组的预期死亡人数。结果:美因河畔法兰克福2020-2023年经年龄和人口趋势调整的死亡率评估更新显示,死亡率过高(SMR 1.029;95% CI 1.004-1.054, +185例超额死亡),其次是2023年的负超额死亡率(SMR 0.972;95% ci 0.948-0.996)。然而,在2020年和2021年,没有发现超额死亡率增加(2020年:SMR 0.976;95% ci 0.951-1.001;2021: 0.998;95% ci 0,973-1.023)。在第二波武汉型SARS CoV-2大流行(2020年秋季)中,发现死亡率显著增加(SMR 1.106;95% CI 1.066-1.147, +274例死亡),以及前四波总体(武汉型、阿尔法型和德尔塔型)(SMR 1.023;95 CI 1.001-1.045),而在2022年的Omikron变异的进一步波浪中,死亡率没有增加(SMR 0.988;95% ci 0.963-1.014)。2022年死亡率的增加与该年最后6周的流感浪潮有关,导致死亡率大幅上升(SMR 1.250;95% ci 1.170-1.330)。讨论:在SARS-CoV-2大流行期间,美因河畔法兰克福仅在引入疫苗接种之前的2020年底的第二波中出现了显著的超额死亡率;在所有其他波浪中,没有记录到明显的超额死亡率。总体而言,美因河畔法兰克福在2020年和2021年出现了非显著负超额死亡率,在2023年出现了显著负超额死亡率。然而,在2022年,观察到死亡率大幅增加,这不能归因于SARS-CoV-2,而是归因于该年底最后6周的短暂、强烈的流感浪潮,这也导致整个德国的死亡率大幅上升。这波流感与美因河畔法兰克福的高死亡率有关,高于美因河畔法兰克福的任何一波SARS-CoV-2大流行。流感波期间的超额死亡人数大于所有SARS-CoV-2波期间的超额死亡人数。在对这一流行病进行评估时,应该考虑到这一显著事实,德国在许多方面越来越多地要求进行这一进程,但目前仍悬而未决。
{"title":"Mortality in Frankfurt am Main, Germany, 2020-2023: higher excess mortality during an influenza wave in 2022 than during all COVID-19 waves altogether.","authors":"Ursel Heudorf, Bernd Kowall","doi":"10.3205/dgkh000533","DOIUrl":"https://doi.org/10.3205/dgkh000533","url":null,"abstract":"<p><strong>Introduction: </strong>Mortality during the SARS-CoV-2 pandemic was studied in many countries. The results were strongly influenced by the chosen calculation method, the adjustment to the ageing of the population and the reference periods used. Smaller-scale studies sometimes showed considerable differences within countries, but it is unclear whether the differences within a country were due to the fact that the studies were small (sampling error) or whether they were true differences. In an earlier small-scale study in Frankfurt, we examined mortality during the first two years of the pandemic. Our aim was to continue this analysis until the end of 2023, for the first time taking into account other factors influencing mortality such as influenza and heat.</p><p><strong>Method: </strong>We obtained population data for Frankfurt am Main for 2016-2023 from the Municipal Office of Statistics, City of Frankfurt/Main, mortality data from 2016 to 2023 from the Hessian State Office for Health and Care, data on SARS-CoV-2 and influenza notifications from the homepage of the Robert Koch-Institute and weather data from the homepage of the German Meteorological Office. For calculating standardized mortality ratios (SMR= observed number of deaths divided by the expected number of deaths), we multiplied the mean mortality rate for 5 age groups from 2016-2019 with the total numer of residents in those age groups in the further years or periods, and finally added the numbers of expected deaths per age group.</p><p><strong>Results: </strong>The update of the assessment of mortality adjusted for age and population trend in the years 2020-2023 in Frankfurt am Main shows an excess mortality (SMR 1.029; 95% CI 1.004-1.054, +185 excess deaths) in 2022, followed by a negative excess mortality in 2023 (SMR 0.972; 95% CI 0.948-0.996). In the years 2020 and 2021 however, no increase in excess mortality had been found (2020: SMR 0.976; 95% CI 0.951-1.001; 2021: 0.998; 95% CI 0,973-1.023). In the second wave of the SARS CoV-2 pandemic with the Wuhan type (fall 2020), a significantly increased mortality was found (SMR 1.106; 95% CI 1.066-1.147, +274 deaths), as well as during the first four waves overall (Wuhan, Alpha and Delta type) (SMR 1.023; 95 CI 1.001-1.045), whereas no increased mortality occurred during the further waves with the Omikron variant in 2022 (SMR 0.988; 95% CI 0.963-1.014). The increased mortality in 2022 was associated with an influenza wave in the last 6 weeks of the year, which had led to a strong increase in mortality (SMR 1.250; 95% CI 1.170-1.330).</p><p><strong>Discussion: </strong>During the SARS-CoV-2 pandemic, significant excess mortality occurred in Frankfurt am Main only in the second wave at the end of 2020 before vaccination was introduced; in all other waves, no significant excess mortality was recorded. Overall, there was a non-significant negative excess mortality in Frankfurt am Main in 2020 and 2021 and a significant negativ","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc04"},"PeriodicalIF":1.7,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059809/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143997259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-04eCollection Date: 2025-01-01DOI: 10.3205/dgkh000532
Heera Hassan, Aravind Reghukumar, Jyothi Rajahamsan, Sreenadh Harikumar, Manjusree Shanmugham
Background: Inappropriate and excessive use of antimicrobials contributes to the rise of antimicrobial resistance (AMR). To address this, better tools are needed to improve antibiotic prescribing globally. This study evaluates a novel antimicrobial stewardship (AMS) tool - the AWaRe-based microbiology reporting format - developed by the Departments of Microbiology and Infectious Diseases at the Government Medical College, Trivandrum, Kerala state, India. This format incorporates the WHO AWaRe classification into bacterial culture susceptibility reports. The primary objective was to assess the effectiveness of this reporting format in encouraging physicians to choose access antibiotics. The secondary objective was to identify the most preferred microbiology reporting format for antimicrobial susceptibility reports.
Materials and methods: A cross-sectional study was conducted among registered modern-medicine practitioners (physicians) in Kerala via social media platforms using a Google form-based questionnaire over a two-month period. Responses were automatically recorded and analysed using descriptive statistical methods. The study included all physicians who gave informed consent, excluding those who declined to participate. The sample size was determined to be 138 based on a pilot study.
Results: A total of 228 physicians participated in the study, 137 (60.1%) of which were clinicians. Among the participants, 199 (87.2%) preferred the AWaRe-based reporting format over conventional formats for effective implementation of the Antimicrobial Stewardship Programme (AMSP). Using this AMS tool, 76.7% (n=56) of participants were successfully guided to choose appropriate access antibiotics.
Conclusion: The study demonstrates that AWaRe-based susceptibility reporting formats can effectively nudge clinicians towards better antibiotic selection, supporting the successful implementation of AMSP (antibiotic stewardship programs). This format also serves as a continuous IEC (Information, Education and Communication) tool, helping clinicians familiarize themselves with WHO AWaRe classifications and encouraging the preferential selection of access-group antibiotics when appropriate.
{"title":"Enhancing antibiotic stewardship: Physicians' acceptance of AWaRe (Access, Watch, Reserve)-based microbiology reporting and its impact on judicious antibiotic selection - a cross-sectional study.","authors":"Heera Hassan, Aravind Reghukumar, Jyothi Rajahamsan, Sreenadh Harikumar, Manjusree Shanmugham","doi":"10.3205/dgkh000532","DOIUrl":"https://doi.org/10.3205/dgkh000532","url":null,"abstract":"<p><strong>Background: </strong>Inappropriate and excessive use of antimicrobials contributes to the rise of antimicrobial resistance (AMR). To address this, better tools are needed to improve antibiotic prescribing globally. This study evaluates a novel antimicrobial stewardship (AMS) tool - the AWaRe-based microbiology reporting format - developed by the Departments of Microbiology and Infectious Diseases at the Government Medical College, Trivandrum, Kerala state, India. This format incorporates the WHO AWaRe classification into bacterial culture susceptibility reports. The primary objective was to assess the effectiveness of this reporting format in encouraging physicians to choose access antibiotics. The secondary objective was to identify the most preferred microbiology reporting format for antimicrobial susceptibility reports.</p><p><strong>Materials and methods: </strong>A cross-sectional study was conducted among registered modern-medicine practitioners (physicians) in Kerala via social media platforms using a Google form-based questionnaire over a two-month period. Responses were automatically recorded and analysed using descriptive statistical methods. The study included all physicians who gave informed consent, excluding those who declined to participate. The sample size was determined to be 138 based on a pilot study.</p><p><strong>Results: </strong>A total of 228 physicians participated in the study, 137 (60.1%) of which were clinicians. Among the participants, 199 (87.2%) preferred the AWaRe-based reporting format over conventional formats for effective implementation of the Antimicrobial Stewardship Programme (AMSP). Using this AMS tool, 76.7% (n=56) of participants were successfully guided to choose appropriate access antibiotics.</p><p><strong>Conclusion: </strong>The study demonstrates that AWaRe-based susceptibility reporting formats can effectively nudge clinicians towards better antibiotic selection, supporting the successful implementation of AMSP (antibiotic stewardship programs). This format also serves as a continuous IEC (Information, Education and Communication) tool, helping clinicians familiarize themselves with WHO AWaRe classifications and encouraging the preferential selection of access-group antibiotics when appropriate.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc03"},"PeriodicalIF":1.7,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143967741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-24eCollection Date: 2025-01-01DOI: 10.3205/dgkh000531
Dominic Rauschning, Ruth Weppler, Carsten Balczun, Gwendolyn Scheumann, Jasmin Monteiro Marques, Christina Mutschnik, Dominic Preuß, Ricarda Maria Schmithausen, Maximilian Starke, Ralf Matthias Hagen, Manuel Döhla
In the spring of 2022, SARS-CoV-2 Omicron BA.2 peaked in Germany. The main burden was staff shortage. To achieve effective identification and management of infected persons as well as early reintegration of recovered persons, an infection-control outpatient clinic was established at the Bundeswehr Central Hospital Koblenz. This article reports a secondary data analysis of 663 people with 1,174 visits to the outpatient clinic. For asymptomatic contacts, no correlation was observed between PCR result and testing time or frequency. Although no significant symptoms were documented, a high correlation was found between a positive antigen self-test and positive PCR. For clearance, a median time until a negative test was obtained was 8-11 days. The PCR gold standard was compared with ECLIA antigen testing for all indications. The results of this study challenge the rationale for testing asymptomatic contacts. Solely symptom-driven diagnostics by PCR also do not seem to be effective. However, contact persons or symptomatic persons with a positive rapid antigen test should be tested further. Whether this testing is done by ECLIA or PCR does not seem to matter. Clearance testing after recovery prior to day 8 is also not appropriate.
{"title":"Clinical and molecular fingerprint of SARS-CoV-2 among hospital employees in a period of Omicron BA.2 dominance.","authors":"Dominic Rauschning, Ruth Weppler, Carsten Balczun, Gwendolyn Scheumann, Jasmin Monteiro Marques, Christina Mutschnik, Dominic Preuß, Ricarda Maria Schmithausen, Maximilian Starke, Ralf Matthias Hagen, Manuel Döhla","doi":"10.3205/dgkh000531","DOIUrl":"https://doi.org/10.3205/dgkh000531","url":null,"abstract":"<p><p>In the spring of 2022, SARS-CoV-2 Omicron BA.2 peaked in Germany. The main burden was staff shortage. To achieve effective identification and management of infected persons as well as early reintegration of recovered persons, an infection-control outpatient clinic was established at the Bundeswehr Central Hospital Koblenz. This article reports a secondary data analysis of 663 people with 1,174 visits to the outpatient clinic. For asymptomatic contacts, no correlation was observed between PCR result and testing time or frequency. Although no significant symptoms were documented, a high correlation was found between a positive antigen self-test and positive PCR. For clearance, a median time until a negative test was obtained was 8-11 days. The PCR gold standard was compared with ECLIA antigen testing for all indications. The results of this study challenge the rationale for testing asymptomatic contacts. Solely symptom-driven diagnostics by PCR also do not seem to be effective. However, contact persons or symptomatic persons with a positive rapid antigen test should be tested further. Whether this testing is done by ECLIA or PCR does not seem to matter. Clearance testing after recovery prior to day 8 is also not appropriate.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc02"},"PeriodicalIF":1.7,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143997257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-24eCollection Date: 2025-01-01DOI: 10.3205/dgkh000530
Tina Peiter, Fergus de Grey-Warter, Tessa Stahl, Thomas Hallet, Derek Matthews, Maren Eggers
Aim: Too often, antibiotics are prescribed in the treatment of pharyngitis, which can contribute to antimicrobial resistance. We aimed to assess the in vitro antiviral and antimicrobial activity of sugar-free cetylpyridinium chloride (CPC)/benzocaine lozenges, which can potentially offer a more suitable treatment for pharyngitis.
Methods: The antiviral activity of sugar-free CPC/benzocaine (1.4 mg/10 mg) lozenges (Dolo-Dobendan 1.4 mg/10 mg lozenges) was assessed using the DIN EN 14476:2019-10 suspension test against bovine coronavirus (S379 Reims) or influenza virus A (H1N1/Brisbane/59/2007) under clean and dirty conditions. Viral titers were measured after 1, 5, 10, and 30 min exposure; a reduction of ≥4 lg was considered virucidal. For bovine coronavirus, large volume plating was used due to cytotoxicity. Antimicrobial activity was measured against 11 microorganisms associated with pharyngitis, with contact times of 1, 5, and 10 min (+30 min for positive control).
Results: For influenza, sugar-free lozenges showed ≥4 lg efficacy from 5 and 10 min exposure under clean and dirty conditions, respectively. For bovine coronavirus, sugar-free lozenges exhibited ≥4 lg efficacy at 10 min under both conditions. Bactericidal activity was observed against nine of the challenge microorganisms within 5 min, with plate counts of <10 colony-forming units (CFU)/mL for Pseudomonas aeruginosa, Staphylococcus aureus, Arcanobacterium haemolyticum, Moraxella catarrhalis, Porphyromonas gingivalis, Prevotelia intermedia, Streptococcus dysgalactiae, and Streptococcus pyogenes, and <100 CFU/mL for Streptococcus pneumoniae. Candida albicans and Escherichia coli showed counts of <10 CFU/mL at 30 min.
Conclusions: Sugar-free CPC/benzocaine lozenges can be recommended for uncomplicated pharyngitis and may be more appropriate than antibiotics, helping to mitigate antimicrobial resistance.
{"title":"Bactericidal and virucidal action of cetylpyridinium chloride and benzocaine lozenges against common oropharyngeal pathogens.","authors":"Tina Peiter, Fergus de Grey-Warter, Tessa Stahl, Thomas Hallet, Derek Matthews, Maren Eggers","doi":"10.3205/dgkh000530","DOIUrl":"https://doi.org/10.3205/dgkh000530","url":null,"abstract":"<p><strong>Aim: </strong>Too often, antibiotics are prescribed in the treatment of pharyngitis, which can contribute to antimicrobial resistance. We aimed to assess the in vitro antiviral and antimicrobial activity of sugar-free cetylpyridinium chloride (CPC)/benzocaine lozenges, which can potentially offer a more suitable treatment for pharyngitis.</p><p><strong>Methods: </strong>The antiviral activity of sugar-free CPC/benzocaine (1.4 mg/10 mg) lozenges (Dolo-Dobendan 1.4 mg/10 mg lozenges) was assessed using the DIN EN 14476:2019-10 suspension test against bovine coronavirus (S379 Reims) or influenza virus A (H1N1/Brisbane/59/2007) under clean and dirty conditions. Viral titers were measured after 1, 5, 10, and 30 min exposure; a reduction of ≥4 lg was considered virucidal. For bovine coronavirus, large volume plating was used due to cytotoxicity. Antimicrobial activity was measured against 11 microorganisms associated with pharyngitis, with contact times of 1, 5, and 10 min (+30 min for positive control).</p><p><strong>Results: </strong>For influenza, sugar-free lozenges showed ≥4 lg efficacy from 5 and 10 min exposure under clean and dirty conditions, respectively. For bovine coronavirus, sugar-free lozenges exhibited ≥4 lg efficacy at 10 min under both conditions. Bactericidal activity was observed against nine of the challenge microorganisms within 5 min, with plate counts of <10 colony-forming units (CFU)/mL for <i>Pseudomonas aeruginosa</i>, <i>Staphylococcus aureus</i>, <i>Arcanobacterium haemolyticum</i>, <i>Moraxella catarrhalis</i>, <i>Porphyromonas gingivalis</i>, <i>Prevotelia intermedia</i>, <i>Streptococcus dysgalactiae</i>, and <i>Streptococcus pyogenes</i>, and <100 CFU/mL for <i>Streptococcus pneumoniae. Candida albicans and Escherichia coli</i> showed counts of <10 CFU/mL at 30 min.</p><p><strong>Conclusions: </strong>Sugar-free CPC/benzocaine lozenges can be recommended for uncomplicated pharyngitis and may be more appropriate than antibiotics, helping to mitigate antimicrobial resistance.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc01"},"PeriodicalIF":1.7,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143998607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-16eCollection Date: 2024-01-01DOI: 10.3205/dgkh000520
Revathy Sakthimohan, Ajitha Rajalingam, Thanka Johnson, K Vivek Rajan
Actinomycosis is an endogenous bacterial infection caused by Actinomyces israelii. This bacterium reside on the mucosa of oral cavity, tonsils, and genitourinary tract. Any insult such as trauma, surgery, or foreign body disrupts the mucosal barrier and gives entry to the underlying tissue to cause disease. We describe a rare presentation of Actinomycosis presenting as a nasal polypoidal mass in a young female, an uncommon presentation, thereby causing diagnostic challenge as it may mimic other lesions with similar clinical presentations like fungal polyps, allergic polyps or chronic sinusitis. A 22 year old female presented with history of recurrent upper respiratory tract infection to the ENT Outpatient Department, clinical evaluation showed deviated nasal septum and radiology showed a nasal polyp and patient underwent submucosal resection with middle meatal antrostomy and micro-debrider assisted polypectomy. Histopathology showed respiratory epithelium with underlying stroma showing dense basophilic filamentous organisms surrounded by peripheral eosinophilic clubs that were Gram-positive and Gomori Methanamine Silver stain positive. The disease was diagnosed as Actinomycosis. The disease is a mimicker of various diseases such as nocardiosis, botryomycosis or tuberculosis having a wide range of symptoms and affecting multiple organs. Prevalence of actinomycosis in nasal region is rare thereby increasing the risk of misdiagnosis. Thus, Actinomycosis should be kept as a differential diagnosis in any chronic infectious diseases of the nasal cavity and monitored closely to ensure precise diagnosis and timely management.
{"title":"Actinomycosis masquerading as a nasal polyp - a rare entity and diagnostic challenge.","authors":"Revathy Sakthimohan, Ajitha Rajalingam, Thanka Johnson, K Vivek Rajan","doi":"10.3205/dgkh000520","DOIUrl":"10.3205/dgkh000520","url":null,"abstract":"<p><p>Actinomycosis is an endogenous bacterial infection caused by <i>Actinomyces israelii</i>. This bacterium reside on the mucosa of oral cavity, tonsils, and genitourinary tract. Any insult such as trauma, surgery, or foreign body disrupts the mucosal barrier and gives entry to the underlying tissue to cause disease. We describe a rare presentation of Actinomycosis presenting as a nasal polypoidal mass in a young female, an uncommon presentation, thereby causing diagnostic challenge as it may mimic other lesions with similar clinical presentations like fungal polyps, allergic polyps or chronic sinusitis. A 22 year old female presented with history of recurrent upper respiratory tract infection to the ENT Outpatient Department, clinical evaluation showed deviated nasal septum and radiology showed a nasal polyp and patient underwent submucosal resection with middle meatal antrostomy and micro-debrider assisted polypectomy. Histopathology showed respiratory epithelium with underlying stroma showing dense basophilic filamentous organisms surrounded by peripheral eosinophilic clubs that were Gram-positive and Gomori Methanamine Silver stain positive. The disease was diagnosed as Actinomycosis. The disease is a mimicker of various diseases such as nocardiosis, botryomycosis or tuberculosis having a wide range of symptoms and affecting multiple organs. Prevalence of actinomycosis in nasal region is rare thereby increasing the risk of misdiagnosis. Thus, Actinomycosis should be kept as a differential diagnosis in any chronic infectious diseases of the nasal cavity and monitored closely to ensure precise diagnosis and timely management.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"19 ","pages":"Doc65"},"PeriodicalIF":1.7,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11729697/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142983319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Meningitis is highly prevalent in infant because their immune system is immature and they have less resistance to diseases. Among bacterial agents, Escherichia coli is recognized as one of the most important causes of meningitis in infants.
Case presentation: Herein, we report a case of late-onset meningitis, caused by E. coli (Patient:17-day-old female infant). The patient's body temperature was 39°C, and the initial diagnosis was sepsis. At the doctor's request, the patient underwent the basic tests and was hospitalized in the Neonatal Intensive Care Unit (NICU). In this case, blood culture and CSF culture were negative and positive, respectively. Echogenic particles were observed inside the bladder, indicating possible cystitis. The results of the antibiotic susceptibility tests showed that the meningitis-causing strain of E. coli was susceptible only to amikacin.
Conclusion: Conducting LP and CSF culture seems to be the most important strategy for diagnosing meningitis. It is also recommended to perform LP before taking antibiotics. For identifying the infection, some factors such as fever, CRP test results, CSF parameters (leukocyte count, glucose level, and CSF culture results) should be considered to prevent misdiagnosis.
{"title":"Case report: an infant with late-onset meningitis caused by Escherichia coli.","authors":"Aria Asghari, Saeed Khoshnood, Zahra Mousavi, Hamid Heidari, Farzaneh Peik Falak, Farhad Dadgar, Hossein Ali Rahdar, Hossein Kazemian","doi":"10.3205/dgkh000522","DOIUrl":"10.3205/dgkh000522","url":null,"abstract":"<p><strong>Background: </strong>Meningitis is highly prevalent in infant because their immune system is immature and they have less resistance to diseases. Among bacterial agents, <i>Escherichia coli</i> is recognized as one of the most important causes of meningitis in infants.</p><p><strong>Case presentation: </strong>Herein, we report a case of late-onset meningitis, caused by <i>E. coli</i> (Patient:17-day-old female infant). The patient's body temperature was 39°C, and the initial diagnosis was sepsis. At the doctor's request, the patient underwent the basic tests and was hospitalized in the Neonatal Intensive Care Unit (NICU). In this case, blood culture and CSF culture were negative and positive, respectively. Echogenic particles were observed inside the bladder, indicating possible cystitis. The results of the antibiotic susceptibility tests showed that the meningitis-causing strain of <i>E. coli</i> was susceptible only to amikacin.</p><p><strong>Conclusion: </strong>Conducting LP and CSF culture seems to be the most important strategy for diagnosing meningitis. It is also recommended to perform LP before taking antibiotics. For identifying the infection, some factors such as fever, CRP test results, CSF parameters (leukocyte count, glucose level, and CSF culture results) should be considered to prevent misdiagnosis.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"19 ","pages":"Doc67"},"PeriodicalIF":1.7,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11730437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142983330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}